EcoDrugPlus

Ensembl ID : ENSTNIG00000019655
Gene Symbol: -
1 Cross references
203 Possible Orthologues:

Ensembl ID : ENSTNIG00000019698
Gene Symbol: -
1 Cross references
200 Possible Orthologues:

Ensembl ID : ENSTNIG00000019701
Gene Symbol: -
1 Cross references
150 Possible Orthologues:

Ensembl ID : ENSTNIG00000019744
Gene Symbol: RPS25
2 Cross references
460 Possible Orthologues:

Ensembl ID : ENSTNIG00000005149
Gene Symbol: -
1 Cross references
36 Possible Orthologues:

Ensembl ID : ENSTNIG00000000023
Gene Symbol: -
1 Cross references
213 Possible Orthologues:

Ensembl ID : ENSTNIG00000002482
Gene Symbol: RPL18A
2 Cross references
367 Possible Orthologues:

Ensembl ID : ENSTNIG00000002839
Gene Symbol: -
1 Cross references
188 Possible Orthologues:

Ensembl ID : ENSTNIG00000004011
Gene Symbol: -
1 Cross references
47 Possible Orthologues:

Ensembl ID : ENSTNIG00000005568
Gene Symbol: -
1 Cross references
268 Possible Orthologues:

Ensembl ID : ENSTNIG00000005753
Gene Symbol: -
1 Cross references
121 Possible Orthologues:

Ensembl ID : ENSTNIG00000006061
Gene Symbol: PSMD11B
2 Cross references
219 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).